Copenhagen Corporate Finance has acted as financial advisor to Viramal Ltd. in raising capital from new and existing Danish investors during Spring 2018.
Viramal is a pharmaceutical company focused on improving the standard of living for millions of women and with profitable growth opportunities based on a valuable technology platform and several interesting pharmaceutical products under development. The first license agreement has been concluded.
Viramal is located in London, UK with a strong link to Denmark through Danish CMO and cooperation with Danish companies.
Copenhagen Corporate Finance has facilitated the process and secured the requisited capital from a Family Office and private investors, as well as initiated the preparations for a upcoming Series-B round.